(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIOMATRIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BIOMATRIX

ST13

US500000090004719

Class

35, 44

Filing

90004719

Registration

6244576

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

04/29/2026

Trademark type

Combined

Nice classes

35, 44

Filing date

06/16/2020

Registration date

01/12/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/28/2026

Last transaction

04/29/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

07/17/2015

First use in commerce

07/17/2015

Drawing code

3

Owner type

16

Owner location

Plantation, FL, US

Examiner

GOLD, BARBARA

Current location

Historical data usage

Mark description

The mark consists of the stylized wording "BIOMATRIX" surrounded by square brackets with the left bracket forming the vertical left side of the letter "B" and the right bracket placed to the right and next to the letter "X".

Holders and representatives

Holders

BioMatrix Specialty Pharmacy, LLC

Representatives

Gina L. Durham, Esq. DLA PIPER LLP (US)

Technical classification

Nice Classes

Class 35Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Retail pharmacy services; specialty retail pharmacy services; Health care utilization and review services as they relate to prescription drugspharmaceutical cost management and drug review utilization servicesverification of benefitsprior authorization and review services and coordination of delivery and access to prescription drugs; Specialty pharmacy servicesretail pharmaceutical distributorship services in the field of special purpose infusion-basedinjectable and oral pharmaceuticals; Business administration of pharmacy reimbursement programs and services in the field of specialty pharmaceuticals for health benefit plan subscribers; Pharmaceutical cost management services and drug utilization review services for patients with complex or chronic medical conditionsall of the foregoing not including dietary supplements or nutraceuticals

Class 44

Medical servicesproviding home infusion servicesspecialty infusion servicesambulatory infusion servicesspecialty pharmacy services in the nature of pharmaceutical advice and dispensing of pharmaceuticals; providing in-home and ambulatory dispensing and administering of infusion pharmaceuticals and nutritional therapy services; providing consultation in the dispensing of pharmaceuticals and pharmaceutical advice; Skilled nursing services in the nature of medication assistance and infusion services; home-visit nursing care; Providing medical information regarding prescription drugs and drug therapy; providing medical information regarding patients' prescription drugs and drug therapy; developing and managing comprehensive programs comprising medical drug therapy and physician support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; healthcare services in the nature of providing and administering infusion biologics therapies for transplantimmunologyneurology and hematology; healthcare services in the nature of immunization services; medical evaluation servicesdisease management programs; healthcare assessment services in the field of patient treatment protocols and patient outcomesall of the foregoing not including dietary supplements or nutraceuticals

Publications

History of USPTO decisions and trademark events.

18 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/28/2026

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/28/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/28/2026

E815

TEAS SECTION 8 & 15 RECEIVED

02/03/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/12/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/12/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/27/2020

PUBO

PUBLISHED FOR OPPOSITION

10/27/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/07/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/19/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

09/18/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/18/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

09/18/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/18/2020

DOCK

ASSIGNED TO EXAMINER

09/18/2020

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/15/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/14/2020

NWAP

NEW APPLICATION ENTERED

06/19/2020

Continuous trademark protection

Get notified about every new filing that threatens BIOMATRIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.